The development of estrogen positive feedback is a hallmark of female puberty. Both estrogen 34 and progesterone signaling are required for the functioning of this neuroendocrine feedback 35 loop but the physiological changes that underlie the emergence of estrogen positive feedback 36 remain unknown. Only after puberty does estradiol (E2) facilitate progesterone synthesis in 37 female hypothalamic astrocytes (neuroP) (Mohr et al. 2018) , an event critical for estrogen 38 positive feedback and the LH surge. We hypothesize that prior to puberty, these astrocytes 39 have low levels of membrane estrogen receptor alpha (ERα), making them unable to respond to 40 E2 with increased neuroP synthesis prior to puberty. To test this hypothesis, pure populations of 41 primary astrocyte cultures were derived from female mice at three different stages of 42 development: pre-puberty (postnatal week 3), pubertal onset (week 5), and post-puberty (week 43 8). Hypothalamic astrocyte responses were measured after treatment with E2. Hypothalamic 44 astrocytes increased progesterone synthesis across pubertal development. Prior to puberty, 45 mERα expression was low in hypothalamic astrocytes, but expression increased across 46 puberty. The increase in mERα expression in hypothalamic astrocytes also corresponded with 47 an increase in caveolin-1 protein, PKA phosphorylation, and a more rapid [Ca 2+ ] i flux in 48 response to E2. Together, these results indicate that increased mERα in hypothalamic 49 astrocytes contributed to the post-pubertal response to E2 that results in neuroP synthesis, 50 critical for ovulation. 51
INTRODUCTION 63
Puberty is a complex developmental stage that elicits a barrage of neuroendocrine changes 64 leading to reproductive maturation. In females, the development of reproductive circuits during 65 puberty culminates in the brain responding positively to ovarian estradiol (E2), triggering the 66 luteinizing hormone (LH) surge that underlies ovulation. There is mounting evidence that 67 alongside E2, brain-derived progesterone (neuroP) is needed for full activation of estrogen 68 positive feedback: 1) astrocyte-derived neuroP is crucial for fully stimulating kisspeptin release intracellular calcium levels and rapid P4 synthesis in hypothalamic astrocytes (Micevych et al. 79 2007), which are the source of neuroP. E2-facilitated neuroP synthesis in astrocytes is initiated 80 via membrane-associated ER-alpha (mERα) transactivation of metabotropic glutamate receptor 81 1a (mGluR1a; ). The shuttling of mERα to the plasma membrane and 82 subsequent coupling to an mGluR subtype is regulated by a class of lipid raft proteins, called 83 caveolins (Luoma et al. 2008) . In a process necessary for neuroP synthesis, caveolin-1 shuttles 84 full-length mERα to the plasma membrane in association with mGluR1a. E2 binding initiates 85 excitatory downstream signaling cascades, including IP 3 receptor-dependent intracellular Ca 2+ 86 flux (Chaban et al. 2004 ) and the phosphorylation of PKA (Chen et al. 2014 ). Activated 87 steroidogenic acute regulatory protein (StAR) and translocator protein (TSPO) mediate the 88 transport of cholesterol into the mitochondria where P450scc converts it into pregnenolone. 89
Finally, 3β-hydroxysteroid dehydrogenase (3β-HSD) converts pregnenolone into P4. Rapid E2 90 signaling in female hypothalamic astrocytes, eliciting intracellular Ca 2+ flux and subsequent P4 91 synthesis, occurs within minutes of E2 exposure (Kuo et al. 2010) . 92
Like the LH surge, E2-facilitated neuroP synthesis is observed solely in post-pubertal 93 females. Indeed, astrocytes derived from the adult female hypothalamus respond to E2 94 stimulation with an increase in neuroP synthesis. Recently, Mohr et al. 2018 , formally tested 95 whether systemic administration of E2 to pre-and post-pubertal ovariectomized rats induced 96 neuroP in the hypothalamus. Only post-pubertal female rats had elevated hypothalamic neuroP 97 levels (Mohr et al. 2018) . Moreover, neuroP levels were elevated on proestrus in gonadally 98 intact female rats. Thus, in vivo and in vitro studies suggest that during puberty, hypothalamic 99 astrocytes develop the cellular machinery to respond to E2 with neuroP synthesis. To explore 100 this hypothesis, the present study examined neuroP synthesis, and the sequelae of E2 action in 101 astrocytes that are associated with neuroP synthesis: E2-induced [Ca 2+ ] i , levels of membrane 102
ERα and expression of proteins associated with steroidogenesis at three specific time points in 103 pubertal development (postnatal week 3 -pre-puberty; week 5 -pubertal onset and week 8 -104 post-puberty). Cultures were generated from cohorts containing 8-12 animals (n = 4/age) at a time. In some 115 cases where data are represented as fold change from PND 23 control, the cohort consisted of 116 a PND 23 group with either a PND 35 or PND 60 group. Hypothalamic blocks were dissected 117 with the following boundaries: rostral extent of the optic chiasm, rostral extent of the mammillary 118 bodies, lateral edges of the tuber cinereum, and the top of the third ventricle. The tissue was 119 minced, dissociated by enzymatic treatment with 2.5% trypsin solution (Invitrogen) with DNase I 120 (Sigma #D4263) and incubated in a 37°C water bath where it was agitated every 10 min for 30 121 min. The trypsin was removed and 5 ml DMEM/F12 (Mediatech), supplemented with 10% fetal 122 bovine serum (FBS) (Invitrogen), 1% penicillin (10000 IU/mL)/streptomycin (10000 μ g/mL) 123 solution (Mediatech), and 2 mM L-glutamine (Hyclone) was added. The tissue was triturated 6 124 times with a 5 ml pipette. Cells were plated in T-75 flasks with 10 ml DMEM/F12 (Mediatech), 125 supplemented with 20% fetal bovine serum (FBS) (Invitrogen), 1% penicillin (10000 126 IU/mL)/streptomycin (10000 μ g/mL) solution (Mediatech), and 2 mM L-glutamine (Hyclone) and 127 maintained at 37°C with 5% CO2 for 3 days before the medium was replaced. After 1 week, 128 FBS concentration was decreased to 15%. After 2 weeks, FBS concentration was decreased to 129 10%. Astrocyte cultures were grown to confluence and shaken on an orbital shaker at 200 rpm 130 for 4 hours to eliminate oligodendrocytes and microglia, yielding cultures with >95% glial 131 fibrillary acid protein-immunoreactive astrocytes. Before experimental manipulations, astrocytes 132 were steroid-starved for 2 hours with 5% charcoal-stripped dextran-treated FBS in phenol-free 133 DMEM/F12 medium. Cultures were then treated with vehicle dimethylsulfoxide (DMSO; Sigma-134 Aldrich, cat# D2650) or 17β-estradiol (1 or 10 nM; Sigma-Aldrich, cat #: E-8875) in steroid-free 135 media (see above) for 1 hour at 37°C. After E2 treatment, media was collected for P4 analysis 136 and cells were collected for immunoblotting. 137
138 Progesterone Extraction and ELISA. 139
NeuroP was extracted from conditioned astrocyte media using diethyl ether and frozen at -20°C. 140
Frozen steroids were reconstituted in assay buffer (Cat# 80-0010). Enzo Scientific Progesterone 141 ELISA kit (cat #ADI-900-011) was used to measure [P4], according to manufacturer's 142 instructions. Positive (blank media spiked with 50 ng/ml P4) and negative controls (blank media 143 alone) were run with the samples. Standard curve (R2=0.996). The detectable range of P4 was 144 8.57 -500 pg/ml. Inter-assay coefficients of variation were between 2.7% and 8.3%, and intra-145 assay coefficients of variation were between 4.9% and 7.6%. 146 147 Calcium Imaging. 148
Astrocytes (375,000-570,000) were plated onto poly-d-lysine (0.1 mg/ml; Sigma-Aldrich)-coated 149 glass coverslips and 1-2 days later pretreated for 2 h with 5% charcoal-stripped FBS DMEM/F-150 12 medium. Before imaging, cells were loaded with the calcium indicator Fluo 4-AM (3 μ M; 151 Thermo-Fisher; F14201) dissolved in HBSS with 0.3% DMSO and 0.06% Pluronic F-127 152 (Thermo-Fisher; P3000MP) for 45 min at 37°C. HBSS was used to wash the cells and then 153 glass coverslips were mounted onto a 50-mm chamber insert (Warner Instruments) fixed into 60 154
x 15-mm cell culture dish (Dow Corning) and placed into a QE-2 quick exchange platform 155 (Warner Instruments) for imaging on a Zeiss Examiner D1 microscope, using an Achroplan 156 20/0,50 water immersion objective (Zeiss). A perfusion pump (1 ml/min, 37°C) was used to 157 deliver HBSS before and after application of E2 (100 pM diluted from DMSO-stocks in HBSS, 158 17β-estradiol, Sigma-Aldrich, cat # E-8875) or ATP (30 uM diluted in HBSS; Sigma Aldrich, cat# 159 A2383). Fluo-4AM fluorescence was excited with the 488-nm argon laser, and emission signals 160 above 505 nm were collected. Videos consisted of 1200 frames (512 x 512) taken, on average, 161 every 161.08 ms (6.2 Hz, +/-0.4 ms). Calcium flux was measured as Δ F/F, or the change in 162 fluorescence intensity after E2 or ATP treatment over the fluorescent intensity during HBSS 163 treatment before stimulation. Peak values were defined as the highest Δ F/F value obtained 164 after the perfusion with E2 or ATP. Responding cells were those whose peak values were at 165 least 20% above the baseline value prior to E2 or ATP delivery. 166 167
Cell Surface Biotinylation. 168
Astrocytes were pretreated for 2 h with 5% charcoal-stripped FBS DMEM/F-12 medium and 169 incubated with DMSO vehicle or in the presence 1 nM 17-estradiol (Sigma-Aldrich) in 5% 170 charcoal-stripped FBS DMEM/F-12 medium for 1 h at 37°C. Cells were then washed three times 171 with ice-cold HBSS with Ca 2+ and Mg 2+ buffer and incubated with freshly prepared 0.5 mg/ml 172 EZ-Link Sulfo-NHS-LC-Biotin (Pierce) in HBSS at 4°C for 30 min with gentle agitation. Excess 173 biotin reagent was quenched by rinsing the cells three times with ice-cold glycine buffer (50 mM 174 glycine in HBSS). Cells were scraped into 10 ml of HBSS solution, transferred into a 50 ml 175 conical tube, and centrifuged at 850 x g for 5 min. The pellet was resuspended in 200 μ l of RIPA 176 Lysis Buffer (Santa Cruz Biotechnology) containing the following proteases inhibitors: 1 mM 177 phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 g/ml pepstatin, 1 g/ml leupeptin, 1 g/ml aprotinin, 178 and 1 mM sodium orthovanadate (all inhibitors were from Santa Cruz Biotechnology). The cells 179 were homogenized by passing through a 25 gauge needle 10 times every 10 min for a total of 180 30 min. The cell extract was centrifuged at 14,000 rpm for 5 min at 4°C, and the protein 181 concentration of the supernatant was determined using the bicinchoninic acid (BCA) Assay 182 Table 1 ). Primary 206 incubations lasted overnight, except for ERα (3 nights) and caveolin-1 (2 nights). Blots were 207 then incubated with goat anti-rabbit or mouse IgG horseradish peroxidase (1:10,000; Vector 208 Laboratories) for 2 hours at room temperature. Bands were visualized using an enhanced 209 chemiluminescence (ECL) kit (Thermo Fisher Scientific). Ponceau S (whole-cell) or Flotillin 210 (biotinylation) was used as a loading control, and immunoreactive bands were normalized to 211 obtain the percentage of protein to Ponceau S or Flotillin ratio. Bands were immediately 212 visualized using FluorChem E and analyzed by Alphaview software (Cell Bioscience). To 213 normalize the data as fold change from PND23 vehicle-treated for each target, the same PND23 214 vehicle-treated lysates were included across blots. Samples from similar treatment groups were 215 pooled to achieve a minimum of 10 μg total protein per western blot lane. 216 217
Reverse Transcription Polymerase Chain Reaction (PCR). 218
RNA was extracted from astrocytes using TRIzol (Invitrogen) reagent, according to 219 manufacturer's protocol. Following chloroform extraction of RNA and precipitation with 100% 220 isopropanol, RNA pellet was washed with 75% ethanol/DEPC-treated water. RNA pellets dried 221 for 10 min at room temperature and were re-suspended in DEPC-treated water. RNA 222 concentration and quality was assessed using a spectrophotometer (NanoDrop 1000). RNA was 223 then converted to cDNA using Superscript III First Strand Synthesis Kit (Invitrogen, cat #18080-224 051). cDNA was made using Oligo dTs for Tspo, Esr1, and HSD3B1, and random hexamers for 225 StAR using 1-2 µg RNA. The RT reaction was performed using a thermal cycler (Agilent 226
Technologies, Stratagene Mx3000P) with the following parameters: for Oligo dTs, 50 min at 227 50°C and 5 min at 85°C; for random hexamers, 10 min at 25°C, 1 hr at 50°C, 10 min at 85°C. 228 cDNA was used immediately for qPCR or stored at -20°C for ≤ 1 month. 229
See Table 2 for primer information. PCR reactions were run in duplicate (if using SYBR 230 
RESULTS

249
P4 levels increased across puberty in female mouse hypothalamic astrocytes 250
After treating female mouse hypothalamic astrocytes with 10 nM E2 for 3 hrs, media was 251 collected, steroids were extracted, and neuroP was measured to determine if P4 synthesis 252 increases across pubertal development. Two-way ANOVA with age and hormone treatment as 253 independent variables and neuroP (pg/ml) as the dependent variable was performed and 254 revealed a significant main effect of age (F(2, 16) = 3.9, p = 0.0418). Tukey post-hoc tests 255 comparing [neuroP] at different ages indicated a nearly significant increase in P4 from PND 23 256 to PND 60 (p = 0.053). n= media from 4 T75 flasks/grp for PND23 and PND35, n = media from 257 3 T75 flasks/grp for PND 60. 258
259
E2-induced [Ca 2+ ] i in hypothalamic astrocytes across puberty 260
To determine if the response to E2 changes during pubertal development, prepubertal and adult 261 female mouse hypothalamic astrocytes loaded with a calcium indicator (Fluo-4 AM) were 262 treated with E2 and the change in fluorescence from baseline was monitored using epi-263 fluorescence. Pre-pubertal hypothalamic astrocytes exhibit both an attenuated and sustained 264 release of intracellular calcium in response to E2 treatment, compared with the rapid and 265 transient response of these cells after puberty ( Figure 2B-D) . Unpaired t-tests comparing peak 266 delta F/F indicated that adult responses to 100 pM E2 were significantly higher than the 267 prepubertal responses to 100 pM E2 (t (20) = 7.517, p <0.0001; Figure 2C ). Using ATP as a 268 control for inducing intracellular calcium levels, both pre-and post-pubertal astrocytes were 269 capable of having rapid and equally large responses, however pre-pubertal astrocytes were 270 slower to recover, as indicated by their sustained response ( Figure 2E ). 271
272
Steroidogenic proteins 273
We did not observe any changes in steroidogenic protein expression across pubertal 274 development. Neither levels of mRNA coding for StAR, TSPO, and 3β-HSD, nor the resulting 275 proteins differed at the time points examined. Separate two-way ANOVAs with age and 10 nM 276 E2 treatment as independent variables and fold change in protein (normalized to Ponceau S) 277 from PND 23 vehicle-treated as the dependent variable was performed for StAR, TSPO, and 278 3β-HSD. StAR protein levels did not change across pubertal development in female mouse 279 hypothalamic astrocytes. While age significantly affected TSPO protein levels (F(2,34) = 4.127, 280 p = 0.0249), Tukey post-hoc tests indicated a significant decrease from pre-puberty to puberty 281 (p = 0.0487), whereas prepubertal and adult female astrocytes did not differ in TSPO protein 282 levels. E2 treatment significantly altered 3β-HSD protein levels (F(1,33) = 4.61, p = 0.0392), 283 without any effects of age. Using Bonferroni post-hoc tests to compare the effect of E2 on 3β-284 HSD expression at each age separately revealed no significant differences. One-way ANOVAs 1 0 were performed with age as the independent variable and fold change in mRNA from PND23 286 astrocytes as the dependent variable revealed no significant differences in levels of StAR, 287 TSPO, or 3β-HSD mRNA across pubertal development in female mouse hypothalamic 288 astrocytes in vitro. 289 290
ERα mRNA and membrane ERα 291
Esr1 mRNA levels in female mouse hypothalamic astrocytes harvested from prepubertal, 292 pubertal, and adult female mice were compared using PCR. No changes in Esr1 mRNA were 293 detected across the time points analyzed (one-way ANOVA; p = 0.105; Figure 4A ). 294
Surface biotinylation and western blotting revealed that the protein levels of the full-length 295 (66kDa) ERα changed across pubertal development but not in response to 1 nM E2 treatment 296 ( Figure 4B ). Two-way ANOVA with age and hormone treatment as independent variables and 297 fold change from P23 vehicle-treated mERα protein level as the dependent variable revealed a 298 significant main effect of age on mERα levels (F(2, 55) = 4.403, p = 0.0168). Tukey post-hoc 299 tests comparing mERα at different ages indicated that mERα protein concentration in female 300 mouse hypothalamic astrocytes increased 3.1-fold from pre-to mid-puberty (1.56 ± 0.17 to 4.87 301 ± 1.51, p = 0.0316) and increased 3.2-fold from pre-puberty to adulthood (1.56 ± 0.17 to 5.02 ± 302 0.38, p = 0.0264). Mid-pubertal and adult astrocytes did not differ in mERα concentration (p = 303 0.997). 304 305
Caveolin-1 protein 306
Caveolin proteins are required for ER trafficking to the membrane (Meitzen and Mermelstein, 307 2011). Because ERα increased across development, we also examined the expression of 308 caveolin proteins. Whole-cell lysates of E2 or vehicle treated hypothalamic astrocytes at 309 different ages were analyzed by western blotting (Figure 5 ). Two-way ANOVA with age and 310 hormone treatment as independent variables and the fold change in caveolin-1 protein 311 (normalized to Ponceau S) from vehicle-treated PND 23 astrocytes as the dependent variable 312 revealed a significant main effect of age (F(2, 22) = 7.814, p = 0.0027). Tukey post-hoc tests 313 indicate a significant 3-fold increase in caveolin-1 protein from prepuberty/puberty to adulthood 314 (PND23 < PND60, p = 0.0064; PND35 < PND60, p = 0.0051). 315 316 1 Phosphorylated PKA increased across puberty 317
We did not observe any changes in steroidogenic protein levels from prepuberty into adulthood, 318 but there was a developmental increase in neuroP levels, suggesting that the activation of 319 steroidogenic proteins might be increasing. Membrane ERα signaling activates PKA to 320 phosphorylate StAR and TSPO (Chen et al. 2014 ) to then increase the transport of cholesterol 321 into the mitochondrial matrix (Papadopoulos et al. 2006 ), the rate-limiting step of 322 steroidogenesis. Levels of phospho-PKA from whole-astrocyte lysates were normalized to total 323 PKA at each developmental time point ( Figure 6 ). Two-way ANOVA, with age and hormone 324 treatment as independent variables and the fold change in phospho-PKA/total PKA from PND 325 23 vehicle-treated as the dependent variable, revealed a significant main effect of age (F(2, 43) 326 = 5.29, p = 0.0088). Tukey post-hoc tests indicate a significant ~2-fold increase in phospho-327 PKA/total PKA from prepuberty/puberty to adulthood (PND23 < PND60, p = 0.0054; PND35 < 328 PND60, p = 0.0167). perhaps due to the low-levels of full-length mERα. In these astrocytes, E2 could be signaling 373 through an entirely different membrane-associated receptor, GPR30, whose signaling can 374 mediate rapid E2 effects (Kuo et al. 2010) . As mERα and caveolin-1 increase with 375 development, the E2 increase in hypothalamic neuroP synthesis also increases. 376
We quantified mRNA and proteins levels of steroidogenic proteins to assess whether our 377 observed developmental changes in neuroP synthesis were due to transcriptional or 378 translational modulation. We observed that only protein levels of TSPO decreased significantly 379 from pre-puberty to puberty, with no change seen in response to E2 treatment. TSPO's role in 380 steroidogenesis remains controversial, but TSPO knockouts have implicated this protein in 381 hormone-induced steroidogenesis (Fan et al. 2015) . However, the relatively weak induction of 382 TSPO, and lack of effect on StAR or 3β-HSD suggest that the post-pubertal responsiveness to 383 E2 is not likely attributable to up-regulation of steroidogenically relevant proteins. Given that 384
PKA phosphorylation significantly increased post-pubertally, and that PKA phosphorylation is 385 necessary for the phosphorylation of TSPO and StAR, we predict that TSPO and StAR 386 phosphorylation activation should increase post-pubertally, which would increase neuroP 387
synthesis. 388
In the present study, the developmental effects on hypothalamic astrocytes were 389 stronger than the effects of E2 stimulation, suggesting that these cells undergo dramatic change 390 during puberty. One such change was that the sensitivity to E2 that resulted in neuroP synthesis 391 increased across pubertal development in hypothalamic astrocytes. While prepubertal 392 astrocytes respond rapidly to E2, albeit weakly, only adult astrocytes responded robustly and 393 rapidly to E2 that resulted in PKA phosphorylation and neuroP synthesis. When neuroP is 394 Independent of E2-treatment, pubertal development significantly altered membrane ERα protein 517 levels in surface biotinylated female mouse hypothalamic astrocytes. Full-length mERα levels 518 increased after puberty in surface biotinylated lysates taken from female mouse hypothalamic 519 astrocytes (ME of age, p = 0.0168). Tukey post-hoc tests indicated a significant increase in 520 mERα from pre-puberty to mid-puberty (p = 0.0316) and from pre-puberty to adulthood (p = 521 0.0264). Data are plotted as fold change from P23 vehicle mERα normalized to flotillin ± SEM. 522 *p < 0.05. 523 astrocytes. Independent of E2-treatment, caveolin-1 protein levels significantly increased after 525 puberty in whole-cell lysates taken from female mouse hypothalamic astrocytes (ME of age, p = 526 0.003). Data are plotted as fold change in caveolin-1 protein from P23 vehicle-treated ± SEM. 527 **p < 0.01. Sample size (n) for each condition is indicated within bars. 528 529 Figure 6 . PKA phosphorylation increased across puberty in female mouse hypothalamic 530 astrocytes. Independent of E2-treatment, levels of phosphorylated PKA protein significantly 531 increased after puberty in whole-cell lysates taken from female mouse hypothalamic astrocytes 532 (ME of age, p = 0.0088). Data are plotted as fold change in phosphorylated PKA/total PKA 533 protein from P23 vehicle-treated ± SEM. **p < 0.01. *p < 0.05. Sample size (n) for each 534 condition is indicated within bars. 535 536 
